Robotic neck surgery using retroauricular approach – Experience of 60 procedures
Journal of Robotic Surgery · 2025
DOI: 10.1007/s11701-025-02891-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Robotic Surgery, 2025. Verfasst von Antonio Augusto Bertelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Head and Neck Surgery Division, Department of Surgery - Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil. dr.bertelli@me.com. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Neck Dissection, Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Remote access approaches to the neck have gained attention due to cosmetic concerns with conventional cervical incisions. Their safety, reproducibility, and oncologic outcomes remain to be fully validated. We retrospectively analyzed our initial experience with retroauricular robotic neck surgery using the Da Vinci system. Thirty-two patients were included. Data collected comprised demographics, procedure type, surgical features, and oncological follow-up. Thirty-five surgeries were performed: 13 posterolateral neck dissections (levels II-V) with central (VI), 5 modified radical dissections (I-V), 5 posterolateral dissections (II-V), and 1 super-selective neck dissection (I). Twelve neck dissections were combined with thyroidectomy. Additional procedures included 4 partial thyroidectomies, 3 submandibular gland resections, 3 schwannoma resections, and 1 branchial cyst excision, totaling 60 procedures. Twenty patients had malignant disease (62.5%). Median hospital stay was 2 days (range 1 9), similar to conventional approaches. Complications included 5 temporary nerve palsies, 1 lymphatic fistula, 1 transient hypoparathyroidism, and 1 minor flap necrosis, all managed conservatively; 1 hematoma required reoperation. Conversion to a conventional approach occured in 4 cases (6.7%). No additional intraoperative or postoperative complications were observed. The mean lymph node yield was 54 in posterolateral/radical dissections and 13 in central dissections. Median follow-up of malignant cases was 41.3 months (range 18-56), with a 3-year regional control rate of 94.7%. Our experience with 60 retroauricular robotic procedures demonstrates this approach to be safe, feasible, and oncologically effective, with complication rates, hospital stay, and oncological outcomes comparable to conventional surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Head and Neck Surgery Division, Department of Surgery - Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil. dr.bertelli@me.com.
- Servidor Público Municipal Hospital, São Paulo, Brazil.
- Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
- Santa Casa de São Paulo School of Medical Sciences and Samaritano Higienópolis Hospital, São Paulo, Brazil.
- São Luiz Morumbi Hospital, São Paulo, Brazil.
- Albert Einstein Hospital, São Paulo, Brazil.
Zitieren
APA
Bertelli, A. A., Monazzi, B. V., Jareño, T. T., Barros Silva, L. A., Guedes de Toledo Barros, R., Massarollo, L. C. B., Lira, R. B., & Duvvuri, U. (2025). Robotic neck surgery using retroauricular approach – Experience of 60 procedures. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-025-02891-4
Vancouver
Bertelli AA, Monazzi BV, Jareño TT, Barros Silva LA, Guedes de Toledo Barros R, Massarollo LCB, et al. Robotic neck surgery using retroauricular approach – Experience of 60 procedures. Journal of Robotic Surgery. 2025. doi:10.1007/s11701-025-02891-4
BibTeX
@article{Bertelli2025,
author = {Bertelli, Antonio Augusto and Monazzi, Bruno Vallim and Jareño, Thaís Tuasca and Barros Silva, Leandro Augusto De and Guedes de Toledo Barros, Rafael and Massarollo, Luiz Claudio Bosco and Lira, Renan Bezerra and Duvvuri, Umamaheswar},
title = {Robotic neck surgery using retroauricular approach – Experience of 60 procedures},
journal = {Journal of Robotic Surgery},
year = {2025},
doi = {10.1007/s11701-025-02891-4}
}
EUVIMED